KR20230061310A - Make-up cosmetic composition having immediate effect - Google Patents
Make-up cosmetic composition having immediate effect Download PDFInfo
- Publication number
- KR20230061310A KR20230061310A KR1020230052817A KR20230052817A KR20230061310A KR 20230061310 A KR20230061310 A KR 20230061310A KR 1020230052817 A KR1020230052817 A KR 1020230052817A KR 20230052817 A KR20230052817 A KR 20230052817A KR 20230061310 A KR20230061310 A KR 20230061310A
- Authority
- KR
- South Korea
- Prior art keywords
- powder
- cosmetic composition
- weight
- skin
- silicone elastomer
- Prior art date
Links
- 239000000203 mixture Substances 0.000 title claims abstract description 58
- 239000002537 cosmetic Substances 0.000 title claims abstract description 48
- 230000000694 effects Effects 0.000 title abstract description 29
- 239000000843 powder Substances 0.000 claims abstract description 62
- 229920002379 silicone rubber Polymers 0.000 claims abstract description 24
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims abstract description 16
- 230000007547 defect Effects 0.000 claims description 23
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 claims description 20
- 229940008099 dimethicone Drugs 0.000 claims description 20
- 239000004205 dimethyl polysiloxane Substances 0.000 claims description 20
- 235000013870 dimethyl polysiloxane Nutrition 0.000 claims description 20
- 229920000435 poly(dimethylsiloxane) Polymers 0.000 claims description 20
- 229920006037 cross link polymer Polymers 0.000 claims description 16
- 238000009472 formulation Methods 0.000 claims description 15
- 239000000049 pigment Substances 0.000 claims description 15
- 229920003229 poly(methyl methacrylate) Polymers 0.000 claims description 15
- 239000004926 polymethyl methacrylate Substances 0.000 claims description 15
- 239000000377 silicon dioxide Substances 0.000 claims description 10
- 239000006071 cream Substances 0.000 claims description 8
- 239000004094 surface-active agent Substances 0.000 claims description 5
- 239000004606 Fillers/Extenders Substances 0.000 claims description 4
- TZCXTZWJZNENPQ-UHFFFAOYSA-L barium sulfate Chemical compound [Ba+2].[O-]S([O-])(=O)=O TZCXTZWJZNENPQ-UHFFFAOYSA-L 0.000 claims description 4
- 239000010445 mica Substances 0.000 claims description 4
- 229910052618 mica group Inorganic materials 0.000 claims description 4
- GTJOHISYCKPIMT-UHFFFAOYSA-N 2-methylundecane Chemical compound CCCCCCCCCC(C)C GTJOHISYCKPIMT-UHFFFAOYSA-N 0.000 claims description 3
- XMSXQFUHVRWGNA-UHFFFAOYSA-N Decamethylcyclopentasiloxane Chemical compound C[Si]1(C)O[Si](C)(C)O[Si](C)(C)O[Si](C)(C)O[Si](C)(C)O1 XMSXQFUHVRWGNA-UHFFFAOYSA-N 0.000 claims description 3
- SGVYKUFIHHTIFL-UHFFFAOYSA-N Isobutylhexyl Natural products CCCCCCCC(C)C SGVYKUFIHHTIFL-UHFFFAOYSA-N 0.000 claims description 3
- VKPSKYDESGTTFR-UHFFFAOYSA-N isododecane Natural products CC(C)(C)CC(C)CC(C)(C)C VKPSKYDESGTTFR-UHFFFAOYSA-N 0.000 claims description 3
- 238000000034 method Methods 0.000 claims description 3
- 229920002635 polyurethane Polymers 0.000 claims description 3
- 239000004814 polyurethane Substances 0.000 claims description 3
- 239000005995 Aluminium silicate Substances 0.000 claims description 2
- 239000004677 Nylon Substances 0.000 claims description 2
- 239000004698 Polyethylene Substances 0.000 claims description 2
- 239000004793 Polystyrene Substances 0.000 claims description 2
- GWEVSGVZZGPLCZ-UHFFFAOYSA-N Titan oxide Chemical compound O=[Ti]=O GWEVSGVZZGPLCZ-UHFFFAOYSA-N 0.000 claims description 2
- 229910021536 Zeolite Inorganic materials 0.000 claims description 2
- RJDOZRNNYVAULJ-UHFFFAOYSA-L [O--].[O--].[O--].[O--].[O--].[O--].[O--].[O--].[O--].[O--].[F-].[F-].[Mg++].[Mg++].[Mg++].[Al+3].[Si+4].[Si+4].[Si+4].[K+] Chemical compound [O--].[O--].[O--].[O--].[O--].[O--].[O--].[O--].[O--].[O--].[F-].[F-].[Mg++].[Mg++].[Mg++].[Al+3].[Si+4].[Si+4].[Si+4].[K+] RJDOZRNNYVAULJ-UHFFFAOYSA-L 0.000 claims description 2
- PNEYBMLMFCGWSK-UHFFFAOYSA-N aluminium oxide Inorganic materials [O-2].[O-2].[O-2].[Al+3].[Al+3] PNEYBMLMFCGWSK-UHFFFAOYSA-N 0.000 claims description 2
- 235000012211 aluminium silicate Nutrition 0.000 claims description 2
- 239000008346 aqueous phase Substances 0.000 claims description 2
- 229910052916 barium silicate Inorganic materials 0.000 claims description 2
- HMOQPOVBDRFNIU-UHFFFAOYSA-N barium(2+);dioxido(oxo)silane Chemical compound [Ba+2].[O-][Si]([O-])=O HMOQPOVBDRFNIU-UHFFFAOYSA-N 0.000 claims description 2
- HNPSIPDUKPIQMN-UHFFFAOYSA-N dioxosilane;oxo(oxoalumanyloxy)alumane Chemical compound O=[Si]=O.O=[Al]O[Al]=O HNPSIPDUKPIQMN-UHFFFAOYSA-N 0.000 claims description 2
- YGANSGVIUGARFR-UHFFFAOYSA-N dipotassium dioxosilane oxo(oxoalumanyloxy)alumane oxygen(2-) Chemical compound [O--].[K+].[K+].O=[Si]=O.O=[Al]O[Al]=O YGANSGVIUGARFR-UHFFFAOYSA-N 0.000 claims description 2
- 239000001023 inorganic pigment Substances 0.000 claims description 2
- JCDAAXRCMMPNBO-UHFFFAOYSA-N iron(3+);oxygen(2-);titanium(4+) Chemical compound [O-2].[O-2].[O-2].[O-2].[O-2].[O-2].[O-2].[Ti+4].[Ti+4].[Fe+3].[Fe+3] JCDAAXRCMMPNBO-UHFFFAOYSA-N 0.000 claims description 2
- NLYAJNPCOHFWQQ-UHFFFAOYSA-N kaolin Chemical compound O.O.O=[Al]O[Si](=O)O[Si](=O)O[Al]=O NLYAJNPCOHFWQQ-UHFFFAOYSA-N 0.000 claims description 2
- ZLNQQNXFFQJAID-UHFFFAOYSA-L magnesium carbonate Chemical compound [Mg+2].[O-]C([O-])=O ZLNQQNXFFQJAID-UHFFFAOYSA-L 0.000 claims description 2
- 239000001095 magnesium carbonate Substances 0.000 claims description 2
- 229910000021 magnesium carbonate Inorganic materials 0.000 claims description 2
- 229910052627 muscovite Inorganic materials 0.000 claims description 2
- 229920001778 nylon Polymers 0.000 claims description 2
- 239000012860 organic pigment Substances 0.000 claims description 2
- -1 polyethylene Polymers 0.000 claims description 2
- 229920000573 polyethylene Polymers 0.000 claims description 2
- 229920002223 polystyrene Polymers 0.000 claims description 2
- 239000000454 talc Substances 0.000 claims description 2
- 229910052623 talc Inorganic materials 0.000 claims description 2
- OGIDPMRJRNCKJF-UHFFFAOYSA-N titanium oxide Inorganic materials [Ti]=O OGIDPMRJRNCKJF-UHFFFAOYSA-N 0.000 claims description 2
- 239000010457 zeolite Substances 0.000 claims description 2
- 238000000926 separation method Methods 0.000 abstract description 8
- 238000010521 absorption reaction Methods 0.000 abstract description 4
- 230000000052 comparative effect Effects 0.000 description 18
- 238000005259 measurement Methods 0.000 description 17
- 230000037303 wrinkles Effects 0.000 description 16
- 239000001993 wax Substances 0.000 description 13
- 239000003921 oil Substances 0.000 description 12
- 235000019198 oils Nutrition 0.000 description 12
- 239000011148 porous material Substances 0.000 description 12
- 230000036548 skin texture Effects 0.000 description 12
- 239000000839 emulsion Substances 0.000 description 8
- 238000011156 evaluation Methods 0.000 description 6
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 5
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 4
- 239000004909 Moisturizer Substances 0.000 description 4
- 230000007423 decrease Effects 0.000 description 4
- 229920001971 elastomer Polymers 0.000 description 4
- 239000000806 elastomer Substances 0.000 description 4
- 230000001333 moisturizer Effects 0.000 description 4
- 239000012071 phase Substances 0.000 description 4
- DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 description 3
- 239000008213 purified water Substances 0.000 description 3
- 239000007787 solid Substances 0.000 description 3
- 239000000516 sunscreening agent Substances 0.000 description 3
- PUPZLCDOIYMWBV-UHFFFAOYSA-N (+/-)-1,3-Butanediol Chemical compound CC(O)CCO PUPZLCDOIYMWBV-UHFFFAOYSA-N 0.000 description 2
- 239000009261 D 400 Substances 0.000 description 2
- 238000004040 coloring Methods 0.000 description 2
- 230000008602 contraction Effects 0.000 description 2
- DTPCFIHYWYONMD-UHFFFAOYSA-N decaethylene glycol Chemical compound OCCOCCOCCOCCOCCOCCOCCOCCOCCOCCO DTPCFIHYWYONMD-UHFFFAOYSA-N 0.000 description 2
- SZXQTJUDPRGNJN-UHFFFAOYSA-N dipropylene glycol Chemical compound OCCCOCCCO SZXQTJUDPRGNJN-UHFFFAOYSA-N 0.000 description 2
- NOPFSRXAKWQILS-UHFFFAOYSA-N docosan-1-ol Chemical compound CCCCCCCCCCCCCCCCCCCCCCO NOPFSRXAKWQILS-UHFFFAOYSA-N 0.000 description 2
- 235000011187 glycerol Nutrition 0.000 description 2
- BXWNKGSJHAJOGX-UHFFFAOYSA-N hexadecan-1-ol Chemical compound CCCCCCCCCCCCCCCCO BXWNKGSJHAJOGX-UHFFFAOYSA-N 0.000 description 2
- 230000001771 impaired effect Effects 0.000 description 2
- 238000012623 in vivo measurement Methods 0.000 description 2
- HQKMJHAJHXVSDF-UHFFFAOYSA-L magnesium stearate Chemical compound [Mg+2].CCCCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCCCC([O-])=O HQKMJHAJHXVSDF-UHFFFAOYSA-L 0.000 description 2
- GLDOVTGHNKAZLK-UHFFFAOYSA-N octadecan-1-ol Chemical compound CCCCCCCCCCCCCCCCCCO GLDOVTGHNKAZLK-UHFFFAOYSA-N 0.000 description 2
- 239000002245 particle Substances 0.000 description 2
- 230000010363 phase shift Effects 0.000 description 2
- 229920003023 plastic Polymers 0.000 description 2
- 239000004033 plastic Substances 0.000 description 2
- 229920000642 polymer Polymers 0.000 description 2
- 230000001953 sensory effect Effects 0.000 description 2
- PRAKJMSDJKAYCZ-UHFFFAOYSA-N squalane Chemical compound CC(C)CCCC(C)CCCC(C)CCCCC(C)CCCC(C)CCCC(C)C PRAKJMSDJKAYCZ-UHFFFAOYSA-N 0.000 description 2
- 238000007619 statistical method Methods 0.000 description 2
- 238000012360 testing method Methods 0.000 description 2
- HLZKNKRTKFSKGZ-UHFFFAOYSA-N tetradecan-1-ol Chemical compound CCCCCCCCCCCCCCO HLZKNKRTKFSKGZ-UHFFFAOYSA-N 0.000 description 2
- 125000000391 vinyl group Chemical group [H]C([*])=C([H])[H] 0.000 description 2
- 229920002554 vinyl polymer Polymers 0.000 description 2
- KIUKXJAPPMFGSW-DNGZLQJQSA-N (2S,3S,4S,5R,6R)-6-[(2S,3R,4R,5S,6R)-3-Acetamido-2-[(2S,3S,4R,5R,6R)-6-[(2R,3R,4R,5S,6R)-3-acetamido-2,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-2-carboxy-4,5-dihydroxyoxan-3-yl]oxy-5-hydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-3,4,5-trihydroxyoxane-2-carboxylic acid Chemical compound CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O[C@H]2[C@@H]([C@@H](O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@H](O3)C(O)=O)O)[C@H](O)[C@@H](CO)O2)NC(C)=O)[C@@H](C(O)=O)O1 KIUKXJAPPMFGSW-DNGZLQJQSA-N 0.000 description 1
- CUNWUEBNSZSNRX-RKGWDQTMSA-N (2r,3r,4r,5s)-hexane-1,2,3,4,5,6-hexol;(z)-octadec-9-enoic acid Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO.OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO.CCCCCCCC\C=C/CCCCCCCC(O)=O.CCCCCCCC\C=C/CCCCCCCC(O)=O.CCCCCCCC\C=C/CCCCCCCC(O)=O CUNWUEBNSZSNRX-RKGWDQTMSA-N 0.000 description 1
- JNYAEWCLZODPBN-JGWLITMVSA-N (2r,3r,4s)-2-[(1r)-1,2-dihydroxyethyl]oxolane-3,4-diol Chemical compound OC[C@@H](O)[C@H]1OC[C@H](O)[C@H]1O JNYAEWCLZODPBN-JGWLITMVSA-N 0.000 description 1
- DSEKYWAQQVUQTP-XEWMWGOFSA-N (2r,4r,4as,6as,6as,6br,8ar,12ar,14as,14bs)-2-hydroxy-4,4a,6a,6b,8a,11,11,14a-octamethyl-2,4,5,6,6a,7,8,9,10,12,12a,13,14,14b-tetradecahydro-1h-picen-3-one Chemical compound C([C@H]1[C@]2(C)CC[C@@]34C)C(C)(C)CC[C@]1(C)CC[C@]2(C)[C@H]4CC[C@@]1(C)[C@H]3C[C@@H](O)C(=O)[C@@H]1C DSEKYWAQQVUQTP-XEWMWGOFSA-N 0.000 description 1
- BJDAUCLANVMIOB-UHFFFAOYSA-N (3-decanoyloxy-2,2-dimethylpropyl) decanoate Chemical compound CCCCCCCCCC(=O)OCC(C)(C)COC(=O)CCCCCCCCC BJDAUCLANVMIOB-UHFFFAOYSA-N 0.000 description 1
- 229940015975 1,2-hexanediol Drugs 0.000 description 1
- VBICKXHEKHSIBG-UHFFFAOYSA-N 1-monostearoylglycerol Chemical compound CCCCCCCCCCCCCCCCCC(=O)OCC(O)CO VBICKXHEKHSIBG-UHFFFAOYSA-N 0.000 description 1
- CDNNKGWZSNSADW-UHFFFAOYSA-N 2,2,4,4,6,6,8,8,10,10,12,12,14,14,16,16,18,18,20,20-icosamethyl-1,3,5,7,9,11,13,15,17,19-decaoxa-2,4,6,8,10,12,14,16,18,20-decasilacycloicosane Chemical compound C[Si]1(C)O[Si](C)(C)O[Si](C)(C)O[Si](C)(C)O[Si](C)(C)O[Si](C)(C)O[Si](C)(C)O[Si](C)(C)O[Si](C)(C)O[Si](C)(C)O1 CDNNKGWZSNSADW-UHFFFAOYSA-N 0.000 description 1
- LEACJMVNYZDSKR-UHFFFAOYSA-N 2-octyldodecan-1-ol Chemical compound CCCCCCCCCCC(CO)CCCCCCCC LEACJMVNYZDSKR-UHFFFAOYSA-N 0.000 description 1
- BGRXBNZMPMGLQI-UHFFFAOYSA-N 2-octyldodecyl tetradecanoate Chemical compound CCCCCCCCCCCCCC(=O)OCC(CCCCCCCC)CCCCCCCCCC BGRXBNZMPMGLQI-UHFFFAOYSA-N 0.000 description 1
- HIQIXEFWDLTDED-UHFFFAOYSA-N 4-hydroxy-1-piperidin-4-ylpyrrolidin-2-one Chemical compound O=C1CC(O)CN1C1CCNCC1 HIQIXEFWDLTDED-UHFFFAOYSA-N 0.000 description 1
- 229910052582 BN Inorganic materials 0.000 description 1
- KWIUHFFTVRNATP-UHFFFAOYSA-N Betaine Natural products C[N+](C)(C)CC([O-])=O KWIUHFFTVRNATP-UHFFFAOYSA-N 0.000 description 1
- PZNSFCLAULLKQX-UHFFFAOYSA-N Boron nitride Chemical compound N#B PZNSFCLAULLKQX-UHFFFAOYSA-N 0.000 description 1
- SGPMPZKXUXPIBJ-UHFFFAOYSA-N C(C)C(CCCCC(=O)OCC(O)CO)(CC)CC Chemical compound C(C)C(CCCCC(=O)OCC(O)CO)(CC)CC SGPMPZKXUXPIBJ-UHFFFAOYSA-N 0.000 description 1
- 239000004215 Carbon black (E152) Substances 0.000 description 1
- QZKRHPLGUJDVAR-UHFFFAOYSA-K EDTA trisodium salt Chemical compound [Na+].[Na+].[Na+].OC(=O)CN(CC([O-])=O)CCN(CC([O-])=O)CC([O-])=O QZKRHPLGUJDVAR-UHFFFAOYSA-K 0.000 description 1
- 241000196324 Embryophyta Species 0.000 description 1
- 235000019493 Macadamia oil Nutrition 0.000 description 1
- KWIUHFFTVRNATP-UHFFFAOYSA-O N,N,N-trimethylglycinium Chemical compound C[N+](C)(C)CC(O)=O KWIUHFFTVRNATP-UHFFFAOYSA-O 0.000 description 1
- 229920002367 Polyisobutene Polymers 0.000 description 1
- HVUMOYIDDBPOLL-XWVZOOPGSA-N Sorbitan monostearate Chemical compound CCCCCCCCCCCCCCCCCC(=O)OC[C@@H](O)[C@H]1OC[C@H](O)[C@H]1O HVUMOYIDDBPOLL-XWVZOOPGSA-N 0.000 description 1
- 239000004163 Spermaceti wax Substances 0.000 description 1
- 239000000654 additive Substances 0.000 description 1
- 230000002421 anti-septic effect Effects 0.000 description 1
- BTFJIXJJCSYFAL-UHFFFAOYSA-N arachidyl alcohol Natural products CCCCCCCCCCCCCCCCCCCCO BTFJIXJJCSYFAL-UHFFFAOYSA-N 0.000 description 1
- 235000013871 bee wax Nutrition 0.000 description 1
- 239000012166 beeswax Substances 0.000 description 1
- 229960003237 betaine Drugs 0.000 description 1
- 239000004204 candelilla wax Substances 0.000 description 1
- 235000013868 candelilla wax Nutrition 0.000 description 1
- 229940073532 candelilla wax Drugs 0.000 description 1
- 239000004203 carnauba wax Substances 0.000 description 1
- 235000013869 carnauba wax Nutrition 0.000 description 1
- 229960000541 cetyl alcohol Drugs 0.000 description 1
- 239000000306 component Substances 0.000 description 1
- 229940086555 cyclomethicone Drugs 0.000 description 1
- 229940113120 dipropylene glycol Drugs 0.000 description 1
- 229960000735 docosanol Drugs 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 239000000686 essence Substances 0.000 description 1
- 150000002148 esters Chemical class 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 210000000887 face Anatomy 0.000 description 1
- 210000001061 forehead Anatomy 0.000 description 1
- 239000003205 fragrance Substances 0.000 description 1
- 229940075529 glyceryl stearate Drugs 0.000 description 1
- IUJAMGNYPWYUPM-UHFFFAOYSA-N hentriacontane Chemical compound CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCC IUJAMGNYPWYUPM-UHFFFAOYSA-N 0.000 description 1
- XJNUECKWDBNFJV-UHFFFAOYSA-N hexadecyl 2-ethylhexanoate Chemical compound CCCCCCCCCCCCCCCCOC(=O)C(CC)CCCC XJNUECKWDBNFJV-UHFFFAOYSA-N 0.000 description 1
- FHKSXSQHXQEMOK-UHFFFAOYSA-N hexane-1,2-diol Chemical compound CCCCC(O)CO FHKSXSQHXQEMOK-UHFFFAOYSA-N 0.000 description 1
- 229920002674 hyaluronan Polymers 0.000 description 1
- 229960003160 hyaluronic acid Drugs 0.000 description 1
- 229930195733 hydrocarbon Natural products 0.000 description 1
- 150000002430 hydrocarbons Chemical class 0.000 description 1
- 239000004615 ingredient Substances 0.000 description 1
- 230000002401 inhibitory effect Effects 0.000 description 1
- 229910052500 inorganic mineral Inorganic materials 0.000 description 1
- 229940119170 jojoba wax Drugs 0.000 description 1
- 239000006210 lotion Substances 0.000 description 1
- 239000010469 macadamia oil Substances 0.000 description 1
- 235000019359 magnesium stearate Nutrition 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 239000011707 mineral Substances 0.000 description 1
- 239000002480 mineral oil Substances 0.000 description 1
- 235000010446 mineral oil Nutrition 0.000 description 1
- 230000003020 moisturizing effect Effects 0.000 description 1
- 229940043348 myristyl alcohol Drugs 0.000 description 1
- JXTPJDDICSTXJX-UHFFFAOYSA-N n-Triacontane Natural products CCCCCCCCCCCCCCCCCCCCCCCCCCCCCC JXTPJDDICSTXJX-UHFFFAOYSA-N 0.000 description 1
- GOQYKNQRPGWPLP-UHFFFAOYSA-N n-heptadecyl alcohol Natural products CCCCCCCCCCCCCCCCCO GOQYKNQRPGWPLP-UHFFFAOYSA-N 0.000 description 1
- WWZKQHOCKIZLMA-UHFFFAOYSA-N octanoic acid Chemical compound CCCCCCCC(O)=O WWZKQHOCKIZLMA-UHFFFAOYSA-N 0.000 description 1
- 235000008390 olive oil Nutrition 0.000 description 1
- 239000004006 olive oil Substances 0.000 description 1
- 239000012188 paraffin wax Substances 0.000 description 1
- 239000003208 petroleum Substances 0.000 description 1
- 229920001610 polycaprolactone Polymers 0.000 description 1
- 239000004632 polycaprolactone Substances 0.000 description 1
- 229920001296 polysiloxane Polymers 0.000 description 1
- 239000003755 preservative agent Substances 0.000 description 1
- 230000002335 preservative effect Effects 0.000 description 1
- 229960004063 propylene glycol Drugs 0.000 description 1
- 230000001681 protective effect Effects 0.000 description 1
- 239000002994 raw material Substances 0.000 description 1
- 230000002829 reductive effect Effects 0.000 description 1
- 229920002545 silicone oil Polymers 0.000 description 1
- 230000037384 skin absorption Effects 0.000 description 1
- 231100000274 skin absorption Toxicity 0.000 description 1
- 230000037394 skin elasticity Effects 0.000 description 1
- 239000011343 solid material Substances 0.000 description 1
- 229960005078 sorbitan sesquioleate Drugs 0.000 description 1
- 229950011392 sorbitan stearate Drugs 0.000 description 1
- 235000019385 spermaceti wax Nutrition 0.000 description 1
- 235000013599 spices Nutrition 0.000 description 1
- 229940032094 squalane Drugs 0.000 description 1
- 230000006641 stabilisation Effects 0.000 description 1
- 238000011105 stabilization Methods 0.000 description 1
- 229940012831 stearyl alcohol Drugs 0.000 description 1
- 230000000475 sunscreen effect Effects 0.000 description 1
- 230000002195 synergetic effect Effects 0.000 description 1
- 239000001040 synthetic pigment Substances 0.000 description 1
- 238000013519 translation Methods 0.000 description 1
- 230000014616 translation Effects 0.000 description 1
- LADGBHLMCUINGV-UHFFFAOYSA-N tricaprin Chemical compound CCCCCCCCCC(=O)OCC(OC(=O)CCCCCCCCC)COC(=O)CCCCCCCCC LADGBHLMCUINGV-UHFFFAOYSA-N 0.000 description 1
- 235000015112 vegetable and seed oil Nutrition 0.000 description 1
- 239000008158 vegetable oil Substances 0.000 description 1
- 239000002023 wood Substances 0.000 description 1
- 239000000230 xanthan gum Substances 0.000 description 1
- 229920001285 xanthan gum Polymers 0.000 description 1
- 229940082509 xanthan gum Drugs 0.000 description 1
- 235000010493 xanthan gum Nutrition 0.000 description 1
Images
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
- A61K8/84—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds obtained by reactions otherwise than those involving only carbon-carbon unsaturated bonds
- A61K8/89—Polysiloxanes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/19—Cosmetics or similar toiletry preparations characterised by the composition containing inorganic ingredients
- A61K8/25—Silicon; Compounds thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
- A61K8/81—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds obtained by reactions involving only carbon-to-carbon unsaturated bonds
- A61K8/8141—Compositions of homopolymers or copolymers of compounds having one or more unsaturated aliphatic radicals, each having only one carbon-to-carbon double bond, and at least one being terminated by only one carboxyl radical, or of salts, anhydrides, esters, amides, imides or nitriles thereof; Compositions of derivatives of such polymers
- A61K8/8152—Homopolymers or copolymers of esters, e.g. (meth)acrylic acid esters; Compositions of derivatives of such polymers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
- A61K8/84—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds obtained by reactions otherwise than those involving only carbon-carbon unsaturated bonds
- A61K8/87—Polyurethanes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
- A61K8/84—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds obtained by reactions otherwise than those involving only carbon-carbon unsaturated bonds
- A61K8/89—Polysiloxanes
- A61K8/891—Polysiloxanes saturated, e.g. dimethicone, phenyl trimethicone, C24-C28 methicone or stearyl dimethicone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
- A61K8/84—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds obtained by reactions otherwise than those involving only carbon-carbon unsaturated bonds
- A61K8/89—Polysiloxanes
- A61K8/895—Polysiloxanes containing silicon bound to unsaturated aliphatic groups, e.g. vinyl dimethicone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Epidemiology (AREA)
- Birds (AREA)
- Chemical & Material Sciences (AREA)
- Dermatology (AREA)
- Inorganic Chemistry (AREA)
- Cosmetics (AREA)
- Oil, Petroleum & Natural Gas (AREA)
Abstract
Description
본 발명은 피부의 결점을 즉각적으로 은폐할 수 있는 화장료 조성물에 관한 것으로, 보다 구체적으로 특정한 실리콘 엘라스토머 및 분체를 포함하여 피부 결점의 즉각적인 은폐 효과가 현저하게 우수한 화장료 조성물에 관한 것이다.The present invention relates to a cosmetic composition capable of immediately concealing skin imperfections, and more particularly, to a cosmetic composition containing a specific silicone elastomer and powder having a remarkably excellent immediate concealment effect of skin imperfections.
최근 여성들은 자연스러운 화장을 위하여 피부의 색상을 유지하면서 피부의 굴곡을 개선하여 매끈한 피부로 보이도록 하는 욕구가 증가하고 있다. 따라서 기초 화장품만으로도 자연스러운 피부 색상을 나타내면서 피부의 굴곡을 매끄럽게 보이도록 하는 화장품에 대한 연구가 활발히 진행되고 있으며, 바르는 즉시 피부 결점을 보완하는 제품들이 출시되고 있다. [0003] Recently, women have increased the desire to make the skin look smooth by improving the curvature of the skin while maintaining the color of the skin for natural makeup. Therefore, studies on cosmetics that show natural skin color and make the curves of the skin look smooth are being actively conducted with only basic cosmetics, and products that compensate for skin defects as soon as they are applied are being released.
종래의 피부 주름 또는 피부 탄력 등의 피부 상태 개선용 화장료 조성물은 피부에 도포할 경우 피부 개선 효과가 즉각적으로 나타나지 않는 경향이 있다. 일부 실리콘 엘라스토머나 구상 분체를 사용하면 상기 문제를 일부 해결할 수 있으나, 효과를 위해서는 다량 사용해야 하기 때문에 제형이 딱딱해지며 사용감이 무거워져 발림성이 떨어지게 된다. 또한, 저온에서 경시에 따라 왁스 및 고급알코올 성분이 석출되어 안정성이 떨어질 수 있으며, 엘라스토머의 회합에 의한 밀림 현상이 심하게 나타나게 되어 제품으로서의 가치가 없어지는 현상이 발생하게 된다. 이러한 문제를 해결하는 방법으로 엘라스토머의 함량을 줄이고 분체의 함량을 늘리는 방법이 있지만, 이런 경우 제형의 안정화를 이룰 수 없는 또 다른 문제점이 발생하게 된다.Conventional cosmetic compositions for improving skin conditions such as skin wrinkles or skin elasticity tend not to show an immediate skin improvement effect when applied to the skin. Some of the above problems can be solved by using some silicone elastomers or spherical powders, but since a large amount must be used for an effect, the formulation becomes hard and the feeling of use becomes heavy, resulting in poor application. In addition, wax and higher alcohol components are precipitated over time at low temperatures, and stability may be deteriorated, and a shedding phenomenon due to association of elastomers occurs severely, resulting in a loss of value as a product. As a way to solve this problem, there is a method of reducing the content of elastomer and increasing the content of powder, but in this case, another problem that cannot achieve stabilization of the formulation occurs.
본 발명이 해결하고자 하는 과제는 주름 등의 피부 결점에 대한 즉각적인 은폐력이 우수하며, 화장 시 밀림 현상이 적고 사용감이 좋으며, 고 함량의 분체를 함유하면서 제형 안정성이 우수한 피부 결점 은폐용 화장료 조성물을 제공하는 것이다.The problem to be solved by the present invention is excellent in immediate concealment of skin defects such as wrinkles, less slipping during makeup, good feeling of use, and containing a high content of powder, providing a cosmetic composition for concealing skin defects with excellent formulation stability is to do
상기 기술적 과제를 달성하기 위하여, 본 발명은 실리콘 엘라스토머 및 분체를 포함하는 수중유형의 결점 은폐용 화장료 조성물을 제공한다.In order to achieve the above technical problem, the present invention provides an oil-in-water cosmetic composition for concealing defects comprising a silicone elastomer and powder.
본 발명자들은 화장료의 제형 안정성과 함께 피부의 결점을 은폐하는 효과를 향상시키는 동시에, 실리콘 엘라스토머와 분체가 다량 함유된 화장료에서 심각하게 발생하는 밀림 현상을 최소화하기 위해 연구 노력하던 중, 본 발명의 특정한 실리콘 엘라스토머와 분체, 특히 반구형 폴리메틸메타크릴레이트(hemi-spherical PMMA powder)를 조합할 때 엘라스토머의 회합이 억제되고, 흡유력이 상승되어 밀림 현상이 방지되며, 피부 결점의 은폐 효과가 우수한 것을 발견하여 본 발명을 완성하였다.The inventors of the present invention improved the effect of concealing skin defects along with the stability of the formulation of the cosmetic, while striving to minimize the creeping phenomenon that occurs seriously in the cosmetic containing a large amount of silicone elastomer and powder, the specific When silicone elastomer and powder, especially hemi-spherical PMMA powder, are combined, the association of elastomers is suppressed, oil absorption is increased to prevent shedding, and it is found that the effect of hiding skin blemishes is excellent Thus, the present invention was completed.
본 발명에 있어서, 상기 '결점 은폐'의 의미는 피부의 주름 또는 모공을 가리거나, 피부결을 곱고 매끄럽게 보이게 하는 것 등을 포함한다.In the present invention, the meaning of the 'concealment of defects' includes covering wrinkles or pores of the skin, making the skin texture look fine and smooth, and the like.
본 발명의 수중유형의 결점 은폐용 화장료 조성물은 가교결합된 실리콘 엘라스토머(Cross-linked elastomer powder)를 포함한다. 상기 실리콘 엘라스토머는 시판되고 있는 제품을 당업자가 용이하게 선택하여 사용할 수 있으며, 예를 들면 다우코닝사(Dow corning)에서 판매하는 DC9040(사이클로펜타실록산 & 디메치콘 크로스폴리머(Cyclopentasiloxane (and) Dimethicone crosspolymer)), DC9041(디메치콘 & 디메치콘/비닐디메치콘 크로스폴리머(Dimethicone (and) Dimethicone/Vinyl dimethicone crosspolymer)) 또는 DC8050ID(이소도데칸 & 디메치콘/비닐디메치콘 크로스폴리머(Isododecane (and) Dimethicone/Vinyldimethicone crosspolymer)); 일본 신에츠사(Shinetsu)에서 판매하는 KSG-16(디메치콘 & 디메치콘/비닐디메치콘 크로스폴리머(Dimethicone (and) Dimethicone/Vinyl dimethicone crosspolymer)) 또는 KCC의 SM9120G(디메치콘 & 디메치콘/비닐디메치콘 크로스폴리머(Dimethicone (and) Dimethicone/Vinyl dimethicone crosspolymer)) 등을 단독으로 또는 혼합하여 사용할 수 있으나, 이에 한정되는 것은 아니다.The cosmetic composition for concealing oil-in-water defects of the present invention includes cross-linked elastomer powder. The silicone elastomer can be easily selected and used by a person skilled in the art from a commercially available product. For example, DC9040 (Cyclopentasiloxane (and) Dimethicone crosspolymer) sold by Dow Corning , DC9041 (Dimethicone (and) Dimethicone/Vinyldimethicone crosspolymer) or DC8050ID (Isododecane (and) Dimethicone/Vinyldimethicone crosspolymer) )); KSG-16 (Dimethicone (and) Dimethicone/Vinyl dimethicone crosspolymer) sold by Shinetsu in Japan or SM9120G from KCC (Dimethicone & Dimethicone/Vinyldimethicone) Dimethicone (and) Dimethicone/Vinyl dimethicone crosspolymer) and the like may be used alone or in combination, but are not limited thereto.
상기 실리콘 엘라스토머의 함량은 화장료 조성물의 총 중량을 기준으로 0.1 내지 20 중량%, 바람직하게 0.5 내지 15 중량%, 더욱 바람직하게 1 내지 10 중량%로 포함될 수 있다. 실리콘 엘라스토머가 상기 중량 범위 내로 포함될 경우에는, 화장료 조성물이 분체를 높은 함량으로 포함하더라도 제형 안정성, 피부 흡수력, 피부 부착력 및 피부 유연성 등의 사용감이 우수하고, 사용 시 밀림 현상을 최소화 할 수 있다.The content of the silicone elastomer may be included in 0.1 to 20% by weight, preferably 0.5 to 15% by weight, more preferably 1 to 10% by weight based on the total weight of the cosmetic composition. When the silicone elastomer is included within the above weight range, even if the cosmetic composition contains a high content of powder, the feeling of use such as formulation stability, skin absorption, skin adhesion and skin flexibility is excellent, and slippage during use can be minimized.
본 발명의 수중유형의 결점 은폐용 화장료 조성물은 분체를 포함한다. 상기 분체는 통상적으로 1 mm 이하의 입자 크기를 갖는 고체 물질의 집합체를 의미하며, 본 발명에서 사용 가능한 분체는 화장품 분야에서 통상적으로 사용되는 체질안료, 착색안료, 무기자외선차단제 및 분체상 유기자외선차단제 등으로 이루어진 군에서 선택된 어느 하나 이상을 포함한다.The cosmetic composition for concealing the defects of the oil-in-water type of the present invention includes powder. The powder usually means an aggregate of solid materials having a particle size of 1 mm or less, and the powder usable in the present invention is an extender pigment, a coloring pigment, an inorganic sunscreen agent, and a powdery organic sunscreen agent commonly used in the field of cosmetics. It includes any one or more selected from the group consisting of and the like.
상기 분체의 함량은 화장료 조성물의 총 중량을 기준으로 0.1 내지 30 중량%, 바람직하게 0.5 내지 25 중량%, 더욱 바람직하게 1 내지 20 중량%로 포함될 수 있다. 분체가 0.1 중량% 미만일 경우에는 결점 은폐 효과가 미약하며, 30 중량% 초과일 경우에는 사용감이 저해되는 문제가 발생한다.The content of the powder may be included as 0.1 to 30% by weight, preferably 0.5 to 25% by weight, more preferably 1 to 20% by weight based on the total weight of the cosmetic composition. If the powder is less than 0.1% by weight, the effect of concealing defects is weak, and if it is more than 30% by weight, the feeling of use is impaired.
본 발명의 일 실시예에 따르면, 본 발명의 화장료 조성물은 착색안료를 분체부의 총 중량 대비 1 중량% 미만, 바람직하게 0.1 내지 0.8 중량%, 더욱 바람직하게 0.1 내지 0.5 중량%로 포함할 수 있으며, 또는 착색안료를 포함하지 않을 수 있다. 본 발명의 화장료 조성물은 분체부 가운데 착색안료 성분을 전혀 사용하지 않거나, 사용하더라도 상기와 같이 작은 양으로 사용함으로써, 본 발명의 결점 은폐용 화장료를 바른 후에 색조 화장을 하거나, 색조 화장 후에 본 발명의 결점 은폐용 화장료를 덧바를 경우에도, 색조 화장에 의한 피부 색상에 영향을 미치지 않도록 한다. 상기 착색안료는 색조 화장품에서 색을 발현시킬 수 있는 모든 물질을 의미하며, 예를 들면 유기합성색소, 천연 색소 또는 진주광택안료 등을 포함한다.According to one embodiment of the present invention, the cosmetic composition of the present invention may include a colored pigment in an amount of less than 1% by weight, preferably 0.1 to 0.8% by weight, more preferably 0.1 to 0.5% by weight, based on the total weight of the powder part, Alternatively, it may not contain a coloring pigment. The cosmetic composition of the present invention does not use any colored pigment component in the powder part, or even if it is used, it is used in a small amount as described above, so that color makeup is applied after applying the cosmetic for concealing defects of the present invention, or color makeup of the present invention is applied after color makeup. Even when applying cosmetics for concealing blemishes, make sure that the color of the skin is not affected by color makeup. The color pigment refers to any material capable of expressing color in color cosmetics, and includes, for example, organic synthetic pigments, natural pigments, or pearlescent pigments.
본 발명에 있어서, 상기 체질안료는 운모, 활석, 카올린, 알루미나, 규산바륨, 제올라이트, 백운모, 합성운모, 실리카, 탄산마그네슘, 황산바륨, 티탄산철 및 산화티탄 피복운모 등을 포함하는 무기안료; 및 폴리우레탄 파우더, 폴리스타이렌 파우더, 폴리메틸메타크릴레이트 파우더, 폴리에틸렌 파우더 및 나이론 파우더 등을 포함하는 유기안료 등으로 이루어진 군에서 선택된 1종 이상이 포함될 수 있다. 상기 체질안료는 상기 나열된 것에 한정되지 않고, 당업계에 통상적으로 알려져 있는 체질안료, 예를 들어 '신화장품학, 권경옥 외 번역, 도서출판 도화기술, 발행일 1997년 10월 30일'에 기재된 체질안료 등이 본 발명의 화장료 조성물에 체질안료로 사용될 수 있다. In the present invention, the extender pigment is an inorganic pigment including mica, talc, kaolin, alumina, barium silicate, zeolite, muscovite, synthetic mica, silica, magnesium carbonate, barium sulfate, iron titanate, and titanium oxide coated mica; and organic pigments including polyurethane powder, polystyrene powder, polymethyl methacrylate powder, polyethylene powder, and nylon powder. The constitutional pigments are not limited to those listed above, and constitutional pigments commonly known in the art, for example, constitutional pigments described in 'New Cosmetic Science, Kwon Kyung-ok, other translations, book publishing drawing technology, publication date October 30, 1997', etc. It can be used as an extender pigment in the cosmetic composition of the present invention.
본 발명에 있어서, 상기 분체로 사용될 수 있는 폴리우레탄 파우더(Polyurethane powder)는 시판되고 있는 제품을 당업자가 용이하게 선택하여 사용할 수 있으며, 예를 들면 SUNJIN사의 PMMA-X(반구형 폴리메틸메타크릴레이트(Hemi-spherical polymethyl methacrylate)) 또는 PMMA-S(구형 폴리메틸메타크릴레이트(Spherical polymethylmethacrylate)), 및 Toshiki 사의 Toshiki Plastic powder D-40(HDI/트리메틸올 헥실락톤 크로스폴리머 & 실리카(HDI/Trimethylol hexyllactone crosspolymer (and) silica)) 또는 Toshiki plastic powder CS-400(HDI/PPG/폴리카프로락톤 크로스폴리머 & 실리카(HDI/PPG/Polycaprolactone crosspolymer (and) silica)) 등을 단독 또는 혼합하여 사용할 수 있으나, 이에 한정되는 것은 아니다.In the present invention, the polyurethane powder that can be used as the powder can be used by those skilled in the art by easily selecting a commercially available product, for example, SUNJIN's PMMA-X (hemispherical polymethyl methacrylate ( Hemi-spherical polymethyl methacrylate) or PMMA-S (Spherical polymethylmethacrylate), and Toshiki Plastic powder D-40 from Toshiki (HDI/trimethylol hexyllactone crosspolymer & silica (HDI/Trimethylol hexyllactone crosspolymer) (and) silica) or Toshiki plastic powder CS-400 (HDI/PPG/Polycaprolactone crosspolymer (and) silica), etc. may be used alone or in combination, but are limited thereto. it is not going to be
바람직하게, 본 발명의 화장료 조성물은 분체로 반구형 폴리메틸메타크릴레이트(hemi-spherical PMMA powder)를 포함할 수 있으며, 이러한 경우에 기타 다른 분체(예를 들어, 구형 폴리메틸메타크릴레이트 등)를 포함할 경우에 비해 결점 은폐 효과가 더욱 향상된다.Preferably, the cosmetic composition of the present invention may include hemi-spherical PMMA powder as powder, and in this case, other powders (eg, spherical polymethyl methacrylate, etc.) The effect of concealing defects is further improved compared to the case of including it.
상기와 같이 반구형 폴리메틸메타크릴레이트를 사용할 경우에는, 실리콘 엘라스토머의 표면에서 마찰력이 높아 피부에 도포 시 밀림 현상이 발생하지 않고, 난반사 효과가 우수하여 결점 은폐력과 함께 세팅감이 우수하며, 흡유력 또한 높아서 사용감뿐만 아니라 제형 안정성도 우수한 효과가 있다. 반구형 폴리메틸메타크릴레이트의 현미경 관찰 결과를 도 4에 나타내었다.In the case of using hemispherical polymethyl methacrylate as described above, the frictional force is high on the surface of the silicone elastomer, so there is no slipping phenomenon when applied to the skin, and the diffuse reflection effect is excellent, so the defect hiding power and setting feeling are excellent, and the oil absorption power is excellent. In addition, because it is high, not only the feeling of use but also the stability of the formulation have an excellent effect. Microscopic observation results of hemispherical polymethylmethacrylate are shown in FIG. 4 .
본 발명에 있어서, 상기 실리콘 엘라스토머 및 분체는 1 : 0.1~10, 바람직하게 1 : 0.5~5, 더욱 바람직하게 1 : 1~3(실리콘 엘라스토머 : 분체)의 중량비로 포함될 수 있다. 상기 실리콘 엘라스토머 및 분체가 상기 중량비의 범위를 벗어날 경우에는, 파우더 및 실리콘겔로 인한 시너지 효과가 감소하여 피부 결점 은폐력 및 사용감이 저하될 뿐만 아니라 경시 안정성도 저하되는 문제가 발생한다.In the present invention, the silicone elastomer and powder may be included in a weight ratio of 1: 0.1 to 10, preferably 1: 0.5 to 5, and more preferably 1: 1 to 3 (silicone elastomer: powder). When the silicone elastomer and the powder are out of the range of the above weight ratio, the synergistic effect due to the powder and the silicone gel is reduced, resulting in a decrease in skin defect hiding power and a feeling of use, as well as a decrease in stability over time.
본 발명의 수중유형의 결점 은폐용 화장료 조성물의 제형은 크림, 에멀전, 에센스, 화장수, 영양크림, 마사지 크림, 유액, 선스크린 크림, 선 오일, 파운데이션 또는 메이크업 베이스 등으로 제조될 수 있으나, 이에 한정되는 것은 아니다. 바람직하게, 본 발명의 수중유형의 결점 은폐용 화장료 조성물은 크림 타입(유제)으로 제조될 수 있으며, 크림 타입(유제)으로 제조될 경우에 본 발명의 결점 은폐 효과가 우수하게 발휘될 수 있다.The formulation of the cosmetic composition for concealing blemishes of the water-type type of the present invention may be prepared as a cream, emulsion, essence, lotion, nourishing cream, massage cream, emulsion, sunscreen cream, sun oil, foundation or makeup base, but is limited thereto it is not going to be Preferably, the oil-in-water cosmetic composition for concealing blemishes of the present invention may be prepared in a cream type (emulsion), and when prepared in a cream type (emulsion), the flaw concealing effect of the present invention may be excellently exhibited.
본 발명의 결점 은폐용 화장료 조성물은 수상 성분으로 정제수, 보습제, 수용해성 방부제, 향, 잔탄검 또는 트리소디움이디티에이 등을 포함할 수 있으며, 유상 성분으로 왁스, 오일, 친유성 고분자 또는 친유성 계면활성제 등을 포함할 수 있다.The cosmetic composition for concealing defects of the present invention may include purified water, a moisturizer, a water-soluble preservative, fragrance, xanthan gum or trisodium EDTA as an aqueous phase component, and wax, oil, lipophilic polymer or lipophilic polymer as an oil phase component surfactants and the like.
즉, 본 발명의 화장료 조성물은 통상적으로 화장료에 사용되는 보습제, 고급알코올, 오일, 왁스, 정제수 또는 각종 첨가제 등을 포함할 수 있다. 상기 각 성분의 함량 범위는 본 발명의 목적을 저해하지 않는 한, 통상의 범위 내에서 사용 가능하다.That is, the cosmetic composition of the present invention may include a moisturizer, higher alcohol, oil, wax, purified water, or various additives commonly used in cosmetics. The content range of each component may be used within a conventional range, as long as the object of the present invention is not impaired.
상기 왁스는 외관 형태를 유지시키는 고형 성분으로 크림 표면에 광택을 제공하고, 피부에 사용시 보호막을 형성하여 피부를 보호하고 사용감을 무겁게 하기 위해 사용된다. 상기 왁스는 식물계 왁스, 동물계 왁스, 광물계 왁스 및 석유계 왁스 등으로 이루어진 군에서 선택된 어느 하나 이상을 포함하며, 예를 들어, 칸데릴라납, 세레신, 카르나우바납, 파라핀, 목납, 경납, 밀납 또는 마이크로크리스타린납 등이 단독으로 혹은 혼합되어 사용될 수 있다.The wax is a solid component that maintains its appearance and is used to provide gloss to the surface of the cream and to form a protective film when used on the skin to protect the skin and increase the feeling of use. The wax includes at least one selected from the group consisting of plant-based wax, animal-based wax, mineral-based wax, and petroleum-based wax. For example, candelilla wax, ceresin, carnauba wax, paraffin, wood wax, spermaceti wax, beeswax Microcrystaline lead and the like may be used alone or in combination.
또한, 상기 계면활성제는 글리세릴 스테아레이트, 솔비탄 세스퀴올레이트, 솔비탄 스테아레이트, 피이지-10디메치콘 및 솔비탄 올리베이트 등으로 이루어진 군에서 선택된 어느 하나 이상이 사용될 수 있으나, 이에 한정되는 것은 아니다.In addition, the surfactant may be any one or more selected from the group consisting of glyceryl stearate, sorbitan sesquioleate, sorbitan stearate, PEG-10 dimethicone and sorbitan olivate, but is limited thereto It is not.
또한, 상기 고급 알코올은 에멀전의 점도에 가장 큰 영향을 주는 고형 성분으로 세틸알코올, 스테아릴알코올, 베헤닐알코올 또는 미리스틸알코올 등이 단독으로 또는 혼합되어 사용될 수 있으며, 에멀전의 점도를 상승시켜 오일 입자의 회합을 저해하여 제형의 안정성을 향상시킨다. In addition, the higher alcohol is a solid component that has the greatest effect on the viscosity of the emulsion, and cetyl alcohol, stearyl alcohol, behenyl alcohol, or myristyl alcohol may be used alone or in combination, and by increasing the viscosity of the emulsion, oil The stability of the formulation is improved by inhibiting the association of particles.
또한, 상기 오일은 스쿠알란 및 미네랄 오일 등을 포함하는 탄화수소계 오일; 카프릴릭/카프릭 트리글리세라이드, 네오펜틸클리콜디카프레이트, 2-옥틸도데실미리스테이트, 이소프로필미리스테이트, 세틸 2-에틸헥사노에이트, 옥틸도데카놀 및 글리세릴 트리에틸헥사노에이트 등을 포함하는 에스테르계 오일; 올리브 오일, 호호바 오일 및 마카다미아 오일 등을 포함하는 식물성 오일; 및 사이클로메치콘 및 디메치콘 등을 포함하는 실리콘 오일 등으로 이루어진 군에서 선택된 1종 이상이 사용될 수 있으나, 이에 한정되는 것은 아니다. 상기 오일은 왁스와 고급 알코올 등의 고형 성분을 용해시키고, 화장료 조성물의 부착성과 퍼짐성에 영향을 미치는 등, 유상 성분의 선택과 함량에 따라 화장료 조성물의 사용감과 안정성에 영향을 미칠 수 있다.In addition, the oil may include hydrocarbon-based oils including squalane and mineral oil; Caprylic/capric triglyceride, neopentylglycol dicaprate, 2-octyldodecyl myristate, isopropyl myristate, cetyl 2-ethylhexanoate, octyldodecanol and glyceryl triethylhexanoate, etc. An ester-based oil containing; vegetable oils including olive oil, jojoba oil and macadamia oil; And at least one selected from the group consisting of silicone oils including cyclomethicone and dimethicone, etc. may be used, but is not limited thereto. The oil may affect the usability and stability of the cosmetic composition depending on the selection and content of the oily component, such as dissolving solid components such as wax and higher alcohol and affecting the adhesion and spreadability of the cosmetic composition.
또한, 상기 보습제는 글리세린, 부틸렌글리콜, 프로필렌글리콜, 디프로필렌글리콜, 히아루론산 및 베타인 등으로 이루어진 군에서 선택된 어느 하나 이상의 수용성 성분이 사용 가능하다. 상기 보습제는 피부의 보습능을 높여주고, 수상의 극성을 낮추어 극성이 낮은 왁스, 고급알코올 또는 계면활성제가 수상과 상호작용할 수 있게 하여, 에멀전의 안정성에 영향을 줄 수 있다.In addition, as the moisturizer, one or more water-soluble ingredients selected from the group consisting of glycerin, butylene glycol, propylene glycol, dipropylene glycol, hyaluronic acid, and betaine may be used. The moisturizer may increase the moisturizing ability of the skin and lower the polarity of the water phase so that the low polarity wax, higher alcohol or surfactant may interact with the water phase, thereby affecting the stability of the emulsion.
바람직하게, 본 발명에 따른 수중유형의 결점 은폐용 화장료 조성물은 조성물 총 중량 대비 실리콘 엘라스토머 0.1~20 중량%, 분체 0.1~30 중량%, 수상 성분 5~40 중량%, 오일 1~30 중량%, 왁스 1~10 중량% 및 계면활성제 1~5 중량%를 포함할 수 있다. 상기 특정한 함량비의 화장료 조성물은 즉각적인 결점 은폐 효과 및 흡수력이 매우 우수하며, 고온에서 분체의 분리 현상 및 도포 시 밀림 현상이 나타나지 않는다.Preferably, the cosmetic composition for concealing oil-in-water defects according to the present invention contains 0.1 to 20% by weight of silicone elastomer, 0.1 to 30% by weight of powder, 5 to 40% by weight of water phase component, 1 to 30% by weight of oil, It may include 1 to 10% by weight of wax and 1 to 5% by weight of a surfactant. The cosmetic composition having the specific content ratio has an immediate effect of concealing defects and excellent absorbency, and does not show powder separation and slipping during application at high temperatures.
본 발명의 수중유형의 결점 은폐용 화장료 조성물은 즉각적인 피부 결점 은폐 효과와 흡수력이 매우 우수하며, 고온에서 분체의 분리 현상이 일어나지 않고, 피부 도포 시 밀림 현상이 나타나지 않아 도포성이 우수하므로 소비자의 만족도를 높일 수 있다.The water-in-water cosmetic composition for concealing blemishes of the present invention has excellent immediate skin blemish concealing effect and absorption power, does not cause separation of powders at high temperatures, and does not cause slipping when applied to the skin, resulting in excellent applicability, thereby increasing consumer satisfaction. can increase
도 1은 실험예 1에서 비교예 1 및 실시예 1~6에 대하여 미세 주름 은폐 효과를 평가한 결과를 나타낸 막대 그래프이다.
도 2는 실험예 2에서 비교예 1 및 실시예 1~6에 대하여 피부결 개선 효과를 평가한 결과를 나타낸 막대 그래프이다.
도 3은 실험예 3에서 비교예 1 및 실시예 1~6에 대하여 모공 개선 효과를 평가한 결과를 나타낸 막대 그래프이다.
도 4는 반구형 폴리메틸메타크릴레이트(hemi-spherical PMMA) 파우더를 현미경으로 관찰한 사진이다.1 is a bar graph showing the results of evaluating the effect of hiding fine wrinkles with respect to Comparative Example 1 and Examples 1 to 6 in Experimental Example 1.
Figure 2 is a bar graph showing the results of evaluating the skin texture improvement effect with respect to Comparative Example 1 and Examples 1 to 6 in Experimental Example 2.
Figure 3 is a bar graph showing the results of evaluating the pore improvement effect with respect to Comparative Example 1 and Examples 1 to 6 in Experimental Example 3.
4 is a photograph of hemi-spherical PMMA powder observed under a microscope.
이하, 본 발명의 이해를 돕기 위하여 실시예 등을 들어 상세하게 설명하기로 한다. 그러나, 본 발명에 따른 실시예들은 여러 가지 다른 형태로 변형될 수 있으며, 본 발명의 범위가 하기 실시예들에 한정되는 것으로 해석되어서는 안 된다. 본 발명의 실시예들은 당업계에서 평균적인 지식을 가진 자에게 본 발명을 보다 완전하게 설명하기 위해 제공되는 것이다.Hereinafter, examples and the like will be described in detail to aid understanding of the present invention. However, the embodiments according to the present invention can be modified in many different forms, and the scope of the present invention should not be construed as being limited to the following examples. Embodiments of the present invention are provided to more completely explain the present invention to those skilled in the art.
비교예comparative example 1 및 1 and 실시예Example 1~6의 제조 Manufacture of 1~6
하기 표 1에 나타낸 조성 성분과 함량을 사용하여, 통상적인 방법으로 비교예 1 및 실시예 1~6의 조성물(에멀전)을 제조하였다. Compositions (emulsions) of Comparative Example 1 and Examples 1 to 6 were prepared in a conventional manner using the components and contents shown in Table 1 below.
*실리콘 엘라스토머 : DC8050ID(Isododecane (and) Dimethicone/Vinyldimethicone crosspolymer)*Silicone elastomer : DC8050ID (Isododecane (and) Dimethicone/Vinyldimethicone crosspolymer)
*SUNPMMA-X : Hemi-spherical polymethyl methacrylate *SUNPMMA-X : Hemi-spherical polymethyl methacrylate
*SUMPMMA-S : Spherical polymethyl methacrylate*SUMPMMA-S : Spherical polymethyl methacrylate
*Plasticpowder D-400 : HDI/Trimethylol hexyllactone crosspolymer & silica*Plasticpowder D-400 : HDI/Trimethylol hexyllactone crosspolymer & silica
*EPU-2X : HDI/Trimethylol hexyllactone crosspolymer & polymethyl methacrylate & silica*EPU-2X : HDI/Trimethylol hexyllactone crosspolymer & polymethyl methacrylate & silica
*SUNSIL-130 : Silica*SUNSIL-130 : Silica
상기 비교예 1 및 실시예 1~6을 통해 제조된 조성물에 대하여, 피부 결점(주름, 모공, 피부결) 은폐 실험 및 안정성을 평가하였으며, 상세한 평가 방법 및 결과는 다음과 같다.For the compositions prepared in Comparative Example 1 and Examples 1 to 6, skin defects (wrinkles, pores, skin texture) concealment experiments and stability were evaluated, and detailed evaluation methods and results are as follows.
실험예Experimental example 1: 미세 주름(눈가 주름) 은폐 효과 평가 1: Evaluate the effect of concealing fine wrinkles (wrinkles around the eyes)
분체와 실리콘 엘라스토머를 함유한 제형의 즉각적인 미세 주름 은폐 효과를 확인하기 위하여 30~40대 여성 10명을 대상으로 눈가 주름을 측정하였다. 사용한 기기는 PRIMOS(Phaseshift Rapid In vivo Measurement of Skin, GFMesstechnik GmbH, Germany)로, 측정용 고정 장비세트에 안면을 고정한 상태로 눈가 주름을 측정하였다. 매 측정 시 마다 동일한 부위를 측정하고 측정 부위에 피부의 수축 이완과 움직임을 방지하기 위하여 특수 제작된 PRIMOS 측정용 고정 장비세트에 피시험자를 고정한 후 측정하였다. PRIMOS의 3차원 측정은 피부에 투사된 parallel projection stripes가 피부 표면의 높이 차이에 따라 변화되고, 이렇게 변화된 정도는 컴퓨터에 의해 정량적으로 계산된다. PRIMOS에 의해 측정된 눈가 주름 이미지는 3D Matching을 이용하여 측정부위와 일치시키는데 변수(Ra) 값이 작아지면 눈가주름이 개선됨을 의미한다. PRIMOS에 의한 측정되는 변수(Ra)값은 전체 측정범위 안의 프로파일의 최고치들의 산술 평균값을 의미하여 개선율은 아래와 같이 계산하였다. In order to confirm the immediate effect of concealing fine wrinkles of a formulation containing powder and silicone elastomer, wrinkles around the eyes were measured on 10 women in their 30s and 40s. The instrument used was PRIMOS (Phaseshift Rapid In vivo Measurement of Skin, GFMesstechnik GmbH, Germany), and wrinkles around the eyes were measured with the face fixed to a set of fixed equipment for measurement. The same area was measured at every measurement, and the subject was measured after fixing the test subject to a set of specially designed PRIMOS measurement fixtures to prevent contraction, relaxation and movement of the skin at the measurement area. In the 3D measurement of PRIMOS, the parallel projection stripes projected onto the skin change according to the height difference of the skin surface, and the degree of this change is quantitatively calculated by a computer. The image of wrinkles around the eyes measured by PRIMOS is matched with the measurement area using 3D Matching. When the value of the variable (Ra) decreases, it means that wrinkles around the eyes are improved. The variable (Ra) value measured by PRIMOS means the arithmetic average value of the highest values of the profile within the entire measurement range, and the improvement rate was calculated as follows.
[계산식][formula]
비교예 1 및 실시예 1~6의 시료 전/후 PRIMOS를 이용하여 눈가 주름을 측정하였으며, 눈가 주름 개선율의 통계분석 결과는 하기 표 2 및 도 1에 나타내었다.The wrinkles around the eyes were measured using PRIMOS before and after the samples of Comparative Example 1 and Examples 1 to 6, and the statistical analysis results of the improvement rate of wrinkles around the eyes are shown in Table 2 and FIG. 1 below.
측정 결과, 비교예 1에 비해 실시예 1~6의 은폐 효과가 우수한 것을 알 수 있으며, 그 중에서도 SUNPMMA-X를 함유한 실시예 1이 가장 우수한 눈가 주름 개선율(약 16%)을 나타내었다.As a result of the measurement, it can be seen that the hiding effect of Examples 1 to 6 is superior to that of Comparative Example 1, and among them, Example 1 containing SUNPMMA-X showed the best rate of improvement in wrinkles around the eyes (about 16%).
실험예Experimental example 2: 2: 피부결skin texture 개선 효과 평가 Evaluation of improvement effect
분체와 실리콘 엘라스토머를 함유한 제형의 즉각적인 피부결 개선 효과를 확인하기 위하여 30~40대 여성 10명을 대상으로 피부결을 측정하였다. 사용한 기기는 PRIMOS(Phaseshift Rapid In vivo Measurement of Skin, GFMesstechnik GmbH, Germany)로, 측정용 고정 장비세트에 안면을 고정한 상태로 볼 부분을 측정하였다. 매 측정 시 마다 동일한 부위를 측정하고 측정 부위에 피부의 수축 이완과 움직임을 방지하기 위하여 특수 제작된 PRIMOS 측정용 고정 장비세트에 피시험자를 고정한 후 측정하였다. PRIMOS의 3차원 측정은 피부에 투사된 parallel projection stripes가 피부 표면의 높이 차이에 따라 변화되고, 이렇게 변화된 정도는 컴퓨터에 의해 정량적으로 계산된다. PRIMOS에 의해 측정된 피부결 이미지는 3D Matching을 이용하여 측정부위와 일치시키는데 변수(Ra) 값이 작아지면 피부결이 개선됨을 의미한다. PRIMOS에 의한 측정되는 변수(Ra)값은 전체 측정범위 안의 프로파일의 최고치들의 산술 평균값을 의미하여 개선율은 아래와 같이 계산하였다.In order to confirm the immediate skin texture improvement effect of the formulation containing powder and silicone elastomer, the skin texture was measured on 10 women in their 30s and 40s. The instrument used was PRIMOS (Phaseshift Rapid In vivo Measurement of Skin, GFMesstechnik GmbH, Germany), and the cheek area was measured with the face fixed to a fixed equipment set for measurement. The same area was measured at every measurement, and the subject was measured after fixing the test subject to a set of specially designed PRIMOS measurement fixtures to prevent contraction, relaxation and movement of the skin at the measurement area. In the 3D measurement of PRIMOS, the parallel projection stripes projected onto the skin change according to the height difference of the skin surface, and the degree of this change is quantitatively calculated by a computer. The skin texture image measured by PRIMOS is matched with the measured area using 3D Matching, and when the value of the variable (Ra) decreases, it means that the skin texture is improved. The variable (Ra) value measured by PRIMOS means the arithmetic mean value of the highest values of the profile within the entire measurement range, and the improvement rate was calculated as follows.
[계산식][formula]
비교예 1 및 실시예 1~6의 시료 전/후 PRIMOS를 이용하여 볼 부분을 측정하였으며, 피부결 개선율의 통계분석 결과는 하기 표 3 및 도 2에 나타내었다.The cheek area was measured using PRIMOS before and after the samples of Comparative Example 1 and Examples 1 to 6, and the statistical analysis results of skin texture improvement are shown in Table 3 and FIG. 2 below.
측정 결과, 비교예 1에 비해 실시예 1~6의 피부결 개선 효과가 우수함을 알 수 있으며, 그 중에서도 SUNPMMA-X를 함유한 실시예 1이 가장 우수한 피부결 개선율(약 34%)을 나타내었다. As a result of the measurement, it can be seen that the skin texture improvement effect of Examples 1 to 6 is superior to that of Comparative Example 1, and among them, Example 1 containing SUNPMMA-X showed the best skin texture improvement rate (about 34%) .
실험예Experimental example 3: 모공 개선 효과 평가 3: Evaluation of pore improvement effect
30-40대 여성 10명의 피험자의 얼굴을 Janus 영상을 측정하고 Imagpro plus를 이용하여 모공을 도포 전과 도포 후로 분석하였다. 특수하게 제작된 턱받침대와 이마 고정대가 장착되어 있어 촬영 시 일정한 각도를 유지하며 피험자와 카메라의 거리가 항상 일정하게 유지되었다. 매 측정 시 기기 내부에 장착된 스트로보를 이용하여 촬영 조건을 고정한 후 cross 모드로 설정하여 피험자의 안면을 설정하였다. Janus images were measured on the faces of 10 female subjects in their 30s and 40s, and pores were analyzed before and after application using Imagpro plus. A specially designed chin rest and forehead holder were installed so that a certain angle was maintained during shooting, and the distance between the subject and the camera was always kept constant. At each measurement, the photographing conditions were fixed using a strobe installed inside the device, and then the face of the subject was set by setting it to the cross mode.
모공이 많은 양쪽 볼을 측정하였으며 해당 부위 면적에서 모공이 차지하고 있는 면적을 수치화해서 세 영역의 평균값을 나타내었다. 측정값이 높을수록 모공이 넓다는 것을 의미하여 도포 전과 도포 후의 평균값을 비교하여 개선 정도를 백분율로 나타낸 결과를 하기 표 4 및 도 3에 나타내었다. Both cheeks with many pores were measured, and the area occupied by pores in the area of the corresponding area was digitized and the average value of the three areas was shown. The higher the measured value, the wider the pores, and the average values before and after application were compared, and the results showing the degree of improvement in percentage are shown in Table 4 and FIG. 3 below.
[계산식][formula]
측정 결과, 통계적으로 유의하게 사용 직후 모공 개선 효과를 나타내었으며, 비교예 1에 비해 실시예 1-6의 모공 개선 효과가 우수하였으며, 그 중에서도 실시예 1이 가장 우수한 모공 개선율(약 43%)을 나타내었다. As a result of the measurement, a statistically significant pore improvement effect was shown immediately after use, and the pore improvement effect of Examples 1-6 was superior to that of Comparative Example 1, and among them, Example 1 had the best pore improvement rate (about 43%). showed up
실험예Experimental example 4: 결점 개선 관능 평가 4: sensory evaluation of defect improvement
효능에 대한 설문평가는 제품 사용 직후 30-40대 피험자(n=20)가 직접 문답하도록 하였으며, 설문은 1~5 척도(1: 전혀 그렇지 않다; ~ 5: 매우 그렇다)로 평가하였다. 사용감에 대한 설문 문항은 제품 사용 후 1주 후 시점에서 1~5 점 척도(1: 전혀 그렇지 않다; ~5: 매우 좋다)로 평가하였으며, 밀림현상의 경우에도 5점 척도로 평가하였다(1: 밀림현상 있음; ~5: 밀림현상 없음).To evaluate the efficacy, the subjects in their 30s and 40s (n=20) were asked to directly answer questions immediately after using the product, and the questionnaire was evaluated on a 1-5 scale (1: not at all; ~ 5: very much). The questionnaire about the feeling of use was evaluated on a 1-5 point scale (1: not at all; ~5: very good) at the point of one week after product use, and the jungle phenomenon was also evaluated on a 5-point scale (1: There is slipping; ~5: no slipping).
상기 표 5에 나타낸 바와 같이, 결점 개선 관능평가 결과는 SUNPMMA-X를 사용한 실시예 1이 결점 개선 효과가 가장 우수하며, 다른 실시예들에 비해 밀림현상이 없음을 확인하였다. As shown in Table 5, the sensory evaluation results for improving defects confirmed that Example 1 using SUNPMMA-X had the most excellent effect on improving defects and that there was no creeping phenomenon compared to other examples.
실험예Experimental example 5: 제형 안정성 평가 5: Evaluation of formulation stability
상기 비교예 1 및 실시예 1~6을 통해 제조된 조성물에 대하여 제형 안정성을 평가하였다. 분체 분리가 가장 쉽게 되는 45℃ 조건에서 2개월 동안 분체 분리 현상이 일어나기 시작한 날을 기록하여 그 결과를 표 6에 나타내었다.Formulation stability was evaluated for the compositions prepared in Comparative Example 1 and Examples 1 to 6. The day when powder separation began to occur was recorded for 2 months under the condition of 45 ° C., where powder separation is the easiest, and the results are shown in Table 6.
상기 표 6에 나타낸 바와 같이 실시예 1~6은 10일 내지 20일에 분체 분리 현상이 발생하였으며 경도가 급격하게 떨어진 반면, 실시예 1은 제형에서 분체 분리 현상이 일어나지 않고 경도도 안정하게 유지되어 제형 안정성이 우수한 것을 확인할 수 있다.As shown in Table 6, in Examples 1 to 6, powder separation occurred on the 10th to 20th day and the hardness rapidly fell, whereas in Example 1, the powder separation did not occur in the formulation and the hardness remained stable. It can be confirmed that the formulation stability is excellent.
Claims (10)
상기 분체는 HDI/트리메틸올 헥실락톤 크로스폴리머 및 실리카를 포함하는 수중유형의 결점 은폐용 화장료 조성물.Including silicone elastomers and powders,
The powder is an oil-in-water type cosmetic composition for concealing defects comprising HDI / trimethylol hexyllactone crosspolymer and silica.
상기 분체는 HDI/트리메틸올 헥실락톤 크로스폴리머 및 실리카를 포함하는 수중유형의 결점 은폐용 화장료 조성물.
Contains 0.1 to 20% by weight of silicone elastomer, 0.1 to 30% by weight of powder, 5 to 40% by weight of aqueous phase component, 1 to 30% by weight of oil, 1 to 10% by weight of wax, and 1 to 5% by weight of surfactant, based on the total weight of the composition and
The powder is an oil-in-water type cosmetic composition for concealing defects comprising HDI / trimethylol hexyllactone crosspolymer and silica.
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR1020150015469 | 2015-01-30 | ||
KR20150015469 | 2015-01-30 | ||
KR1020160010254A KR102526135B1 (en) | 2015-01-30 | 2016-01-27 | Make-up cosmetic composition having immediate effect |
Related Parent Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
KR1020160010254A Division KR102526135B1 (en) | 2015-01-30 | 2016-01-27 | Make-up cosmetic composition having immediate effect |
Publications (1)
Publication Number | Publication Date |
---|---|
KR20230061310A true KR20230061310A (en) | 2023-05-08 |
Family
ID=56712597
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
KR1020160010254A KR102526135B1 (en) | 2015-01-30 | 2016-01-27 | Make-up cosmetic composition having immediate effect |
KR1020230052817A KR20230061310A (en) | 2015-01-30 | 2023-04-21 | Make-up cosmetic composition having immediate effect |
Family Applications Before (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
KR1020160010254A KR102526135B1 (en) | 2015-01-30 | 2016-01-27 | Make-up cosmetic composition having immediate effect |
Country Status (1)
Country | Link |
---|---|
KR (2) | KR102526135B1 (en) |
Families Citing this family (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR102336132B1 (en) * | 2016-11-11 | 2021-12-07 | (주)아모레퍼시픽 | Makeup cosmetic composition having improved absorbing abilities, coating properties and formability, and method for preparing the same |
KR102370390B1 (en) * | 2017-04-10 | 2022-03-04 | 주식회사 엘지생활건강 | Cosmetic composition for anti-aging |
KR102453891B1 (en) * | 2017-12-08 | 2022-10-11 | (주)아모레퍼시픽 | Cosmetic composition for skin pore-clogging or moisturizing |
KR102417956B1 (en) * | 2020-06-05 | 2022-07-07 | 한국콜마주식회사 | Lip cosmetic composition |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2009155274A (en) * | 2007-12-27 | 2009-07-16 | Shiseido Co Ltd | Water-in-oil type cosmetic for pore-masking use |
KR101569775B1 (en) * | 2009-10-01 | 2015-11-17 | 주식회사 엘지생활건강 | Oil-in-water cream type cosmetics composition for filler |
KR20120042397A (en) * | 2010-10-25 | 2012-05-03 | (주)아모레퍼시픽 | Water-in-oil type cosmetic composition for blocking ultraviolet containing a large amount of silicone elastomer |
KR20120096664A (en) * | 2011-02-23 | 2012-08-31 | 한국콜마 주식회사 | Water in silicone emulsion and oil-based cosmetic composition comprising the same |
EP2877154A4 (en) * | 2012-07-25 | 2016-02-10 | Elc Man Llc | Method and compositions for reducing pore size, and moisturizing and/or blurring appearance of defects on keratin surfaces |
-
2016
- 2016-01-27 KR KR1020160010254A patent/KR102526135B1/en active IP Right Grant
-
2023
- 2023-04-21 KR KR1020230052817A patent/KR20230061310A/en not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
KR102526135B1 (en) | 2023-04-26 |
KR20160094311A (en) | 2016-08-09 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
KR20230061310A (en) | Make-up cosmetic composition having immediate effect | |
CN105916489B (en) | Cosmetic composition | |
JP5695828B2 (en) | Cosmetic composition, method for improving the aesthetic appearance of skin and cosmetic kit | |
EP2229142B1 (en) | Gel technology suitable for use in cosmetic compositions | |
JP6492177B2 (en) | Hydrophilic alcoholic or aqueous gels of synthetic phyllosilicates as thickeners, matte feel imparting agents and / or coating homogenizers | |
JP5219142B2 (en) | Water-in-oil emulsified cosmetic | |
JP2018530580A (en) | Composition comprising soft focus filler and composite pigment based on non-spherical alumina and metal oxide | |
JP6853037B2 (en) | Water-in-oil emulsified cosmetic | |
WO2019091663A1 (en) | Composition with luminous satin effect comprising particles of cellulose, of boron nitride and of satin nacres | |
JP2016124846A (en) | Powder cosmetics | |
WO2014151720A1 (en) | Compositions containing titanate silicone networks | |
US9931293B2 (en) | Cosmetic compositions for minimizing skin imperfections | |
US10470989B2 (en) | Surface-treated powder using theanine, and cosmetic preparation containing same | |
JP4880078B1 (en) | Powder cosmetics | |
WO2014170864A2 (en) | Composition containing an emulsion, the oily phase comprising a compound consisting of a silicone elastomer and a surfactant, a silicone elastomer powder and a polyalkyl (meth)acrylate | |
JP7111480B2 (en) | powdered cosmetics | |
JPH11246354A (en) | Water-in-oil type cosmetic | |
KR102565530B1 (en) | Powdery composition for makeup containing goniochromatic pigment and white pigment | |
JP6903000B2 (en) | Cosmetic composition | |
JP4191976B2 (en) | Oily cosmetics | |
JP2020164458A (en) | Oil-in-water emulsion cosmetic | |
JP2004300093A (en) | Lipstick overcoat | |
KR101495018B1 (en) | Cosmetic composition having magic sensory zone, screening method and preparation method thereof | |
JP7252038B2 (en) | powder cosmetics | |
KR20220148576A (en) | Composition including oil and organic-inorganic composite powder |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A107 | Divisional application of patent | ||
E902 | Notification of reason for refusal |